Stock MDCO THE MEDICINES COMPANY
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases The Medicines Company

Equities

MDCO

US5846881051

Delayed Nasdaq
Other stock markets
 		5-day change 1st Jan Change
- USD -.--% Intraday chart for The Medicines Company +0.14% -0.05%
2020 The Medicines Company Announces Board Changes CI
2020 The Medicines Company(NasdaqGS:MDCO) dropped from S&P 600 Health Care CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Metsera Launches to Lead the Next Generation of Medicines for Obesity and Metabolic Diseases
AQ
The Medicines Company : Announces Effective Date of Make-Whole Fundamental Change Relating To Its 2.50% Convertible Senior Notes Due 2022
AQ
The Medicines Company : Announces Effective Date Of Make-Whole Fundamental Change Relating To Its 2.50% Convertible Senior Notes Due 2022, 2.75% Convertible Senior Notes due 2023 and 3.50% Convertible Senior Notes due 2024
BU
MEDICINES CO /DE : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)
AQ
MEDICINES CO /DE : Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits (form 8-K)
AQ
WeissLaw LLP Investigates The Medicines Co.
PR
Alnylam Pharmaceuticals : Announces 2020 Product and Pipeline Goals and Provides Updates at R&D Day
AQ
Medicines : Novartis to acquire The Medicines Company for USD 9.7 bn, adding inclisiran, a potentially transformational investigational cholesterol-lowering therapy
AQ
MEDICINES CO /DE : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)
AQ
Medicines : WHAT THE OTHER PAPERS SAY THIS MORNING
AQ
Medicines : 24 Nov 2019The Medicines Company Enters Into Definitive Agreement to be Acquired by Novartis AG for $9.7 billion
PU
Medicines : Novartis to buy The Medicines Company for $9.7 billion
AQ
The Medicines Company : Enters Into Definitive Agreement to be Acquired by Novartis AG for $9.7 Billion
BU
Home Depot : Kohl’s slip while Medicines, ServiceNow advance
AQ
Coty : and Medicines jump while HP and ConocoPhillips stumble
AQ
The Medicines Company : Announces that the ORION-9 Study of Inclisiran in HeFH Patients Showed Durable and Potent LDL-C Lowering with Twice-Yearly Dosing
BU
The Medicines Company : Announces that the ORION-10 Study of Inclisiran in ASCVD Patients Showed Durable and Potent Lowering of LDL-C with Twice-Yearly Dosing
AQ
The Medicines Company : Announces that the ORION-10 Study of Inclisiran in ASCVD Patients Showed Durable and Potent Lowering of LDL-C with Twice-Yearly Dosing
BU
Medicines : 06 Nov 2019The Medicines Company to Present Inclisiran Data from ORION-9 and ORION-10 Pivotal Phase 3 Clinical Studies at American Heart Association Scientific Sessions 2019
PU
The Medicines Company : to Present Inclisiran Data from ORION-9 and ORION-10 Pivotal Phase 3 Clinical Studies at American Heart Association Scientific Sessions 2019
BU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. MDCO Stock
  4. News The Medicines Company
  5. Press Releases